A Study to Evaluate the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Episodic Cluster Headache (ECH)
Clinical trial NCT02945046 · TERMINATED
Trial details
- NCT number
- NCT02945046
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-19
- Primary completion
- 2019-05-13
- Enrollment
- 169
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.